Pharma Journalist - Page 872 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Abzena and OBI Pharma Sign ThioBridge Licence Agreement

CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel’s Assuta Medical Center

InMed Pharmaceuticals Signs R&D Agreement with ATERA

Eurofins Has Signed an Exclusive Agreement to Acquire Amatsigroup

Zydus starts phase II trial of ZYAN1 for treating anemia in patients with CKD

FDA grants SOBI003 Orphan Drug Designation for the treatment of MPS IIIA

Exscientia Enters Strategic Drug Discovery Collaboration with GSK

Sun Pharma & Samsung BioLogics announce strategic manufacturing tie-up for Tildrakizumab

Endo Completes Divestiture of Litha Healthcare Group

Arbor Pharmaceuticals, LLC and Debiopharm International SA Announce U.S. FDA Approval for Triptodur